-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At present, digital healthcare is ushering in the global trend, and countries are focusing on the digital transformation of the medical industry and deploying technologies such as artificial intelligence, Internet of Things, cloud computing, and big data
.
Since 2018, China has invested heavily in digital medical research and development, which has also prompted the number of patent applications and patent grants to increase year by year
.
According to data, in the past four years (2018-October 2021), more than 70 countries and regions around the world have filed 84,000 patent applications in the field of digital medicine, showing a rapid growth trend
.
Among them, the number of patent applications in China, the United States and South Korea were 44,950, 15,500 and 5,200 respectively
.
It can be clearly seen that China has developed rapidly in the field of digital medical care, and it has obvious advantages in the number of patent applications
.
The analysis believes that China's current technological achievements in the digital medical field are of high quality, and it has changed the situation of winning only by quantity in the past, and has entered a period of joint development of quantity and quality
.
In the future, as Chinese companies continue to invest in research and development, the quality of patents and technology will make great progress, and a promising era of digital healthcare will usher in
.
In this context, with the development of the digital medical industry and the continuous empowerment of technological advancement, the industry expects that the market scale of China's pharmaceutical e-commerce and online consultation will also enter a stage of rapid growth.
Reached 1.
2 trillion yuan and 407 billion yuan respectively
.
It is worth noting that the huge digital medical market has become a battleground for multinational pharmaceutical companies in addition to domestic companies competing for the end
.
Since 2016, multinational pharmaceutical companies have been accelerating their deployment in five areas: Internet healthcare, digital construction, drug research and development, digital therapy, and real-world data
.
At the same time, in China, a large number of multinational pharmaceutical companies are also accelerating their deployment in the domestic digital medical field through cooperation with domestic Internet platforms and medical companies
.
For example, on November 6, GlaxoSmithKline and Baidu Health signed a memorandum of cooperation at the exhibition area of the 4th CIIE to jointly develop a digital innovation model for disease education and prevention
.
The two parties will use Internet technology to provide safe and suitable health services, actively explore innovative methods such as artificial intelligence to carry out disease science popularization and improve prevention concepts, and use herpes zoster disease prevention as a pilot project to jointly popularize the awareness of herpes zoster disease among middle-aged and elderly people , So as to improve the self-health management ability and health literacy of middle-aged and elderly people
.
Also at the 4th CIIE, Sanofi and JD Health also announced the official launch of the "Centre of Excellence in Diabetes Online Diagnosis and Treatment Service Management" (referred to as the "Centre of Excellence").
A new era of stand-alone digital health management
.
It is understood that the "center of excellence" launched this time creates a closed-loop diagnosis and treatment service based on the entire journey of "pre-diagnosis-during-diagnosis-post-diagnosis" for diabetic patients
.
At present, the "Excellence Center" has more than 15,000 endocrinologists, of whom more than 40% are attending to doctors in the top three hospitals
.
In general, as an important field of people's livelihood development, medical care has become a general trend in its digital transformation
.
In the future, under the background of continuous favorable policies, huge market potential, and more possibilities brought about by technological applications, China's digital medical market will continue to expand, and it will play an increasingly important role in the development of the global digital medical industry
.
.
Since 2018, China has invested heavily in digital medical research and development, which has also prompted the number of patent applications and patent grants to increase year by year
.
According to data, in the past four years (2018-October 2021), more than 70 countries and regions around the world have filed 84,000 patent applications in the field of digital medicine, showing a rapid growth trend
.
Among them, the number of patent applications in China, the United States and South Korea were 44,950, 15,500 and 5,200 respectively
.
It can be clearly seen that China has developed rapidly in the field of digital medical care, and it has obvious advantages in the number of patent applications
.
The analysis believes that China's current technological achievements in the digital medical field are of high quality, and it has changed the situation of winning only by quantity in the past, and has entered a period of joint development of quantity and quality
.
In the future, as Chinese companies continue to invest in research and development, the quality of patents and technology will make great progress, and a promising era of digital healthcare will usher in
.
In this context, with the development of the digital medical industry and the continuous empowerment of technological advancement, the industry expects that the market scale of China's pharmaceutical e-commerce and online consultation will also enter a stage of rapid growth.
Reached 1.
2 trillion yuan and 407 billion yuan respectively
.
It is worth noting that the huge digital medical market has become a battleground for multinational pharmaceutical companies in addition to domestic companies competing for the end
.
Since 2016, multinational pharmaceutical companies have been accelerating their deployment in five areas: Internet healthcare, digital construction, drug research and development, digital therapy, and real-world data
.
At the same time, in China, a large number of multinational pharmaceutical companies are also accelerating their deployment in the domestic digital medical field through cooperation with domestic Internet platforms and medical companies
.
For example, on November 6, GlaxoSmithKline and Baidu Health signed a memorandum of cooperation at the exhibition area of the 4th CIIE to jointly develop a digital innovation model for disease education and prevention
.
The two parties will use Internet technology to provide safe and suitable health services, actively explore innovative methods such as artificial intelligence to carry out disease science popularization and improve prevention concepts, and use herpes zoster disease prevention as a pilot project to jointly popularize the awareness of herpes zoster disease among middle-aged and elderly people , So as to improve the self-health management ability and health literacy of middle-aged and elderly people
.
Also at the 4th CIIE, Sanofi and JD Health also announced the official launch of the "Centre of Excellence in Diabetes Online Diagnosis and Treatment Service Management" (referred to as the "Centre of Excellence").
A new era of stand-alone digital health management
.
It is understood that the "center of excellence" launched this time creates a closed-loop diagnosis and treatment service based on the entire journey of "pre-diagnosis-during-diagnosis-post-diagnosis" for diabetic patients
.
At present, the "Excellence Center" has more than 15,000 endocrinologists, of whom more than 40% are attending to doctors in the top three hospitals
.
In general, as an important field of people's livelihood development, medical care has become a general trend in its digital transformation
.
In the future, under the background of continuous favorable policies, huge market potential, and more possibilities brought about by technological applications, China's digital medical market will continue to expand, and it will play an increasingly important role in the development of the global digital medical industry
.
